What is considered extensive tinea corporis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Extensive Tinea Corporis

Extensive tinea corporis is defined as lesions that cannot be adequately covered with standard dressings, or when multiple widespread lesions are present that require systemic rather than topical therapy alone. 1

Clinical Classification

The distinction between localized and extensive disease determines treatment approach and return-to-activity decisions:

Extensive Disease Criteria

  • Multiple lesions that cannot be covered with standard gas-permeable dressings indicate extensive disease 1
  • Widespread lesions requiring systemic therapy rather than topical treatment alone 1
  • Active lesions confirmed by KOH preparation showing hyphae/arthroconidia or positive fungal culture 1

Localized Disease Criteria (for comparison)

  • Solitary or closely clustered lesions that can be covered with a single gas-permeable dressing 1
  • Amenable to topical therapy alone 1

Important Clinical Context

There is no universally agreed-upon numerical threshold (such as number of lesions or body surface area percentage) that defines extensive disease across all dermatology guidelines 2. The classification is primarily functional—based on whether the infection can be managed with topical therapy and appropriate covering, or requires systemic treatment 1.

Athletic/Contact Sport Considerations

In the context of contact sports (wrestling, judo), the distinction is particularly important:

  • Localized disease: Minimum 72 hours of treatment required before return to contact activities, with lesions covered by gas-permeable dressing 1
  • Extensive disease: Disqualification from contact sports until adequately treated 1
  • Studies show remarkably high prevalence in wrestlers (24-53% infection rates) 2, 3

Treatment Implications

The classification directly determines treatment strategy:

For Extensive Disease

  • Systemic antifungal therapy is indicated 1, 4, 5
  • Itraconazole 100 mg daily for 15 days achieves 87% mycological cure rate (superior to griseofulvin's 57%) 2, 1
  • Terbinafine is superior for Trichophyton tonsurans infections, the most common pathogen in athletic populations (>80% of cases) 2, 1, 3

For Localized Disease

  • Topical antifungals are generally sufficient 6, 4
  • Treatment duration typically 2-4 weeks 7, 6

Common Pitfalls

  • Do not rely solely on clinical appearance to determine extent—laboratory confirmation with KOH preparation or culture is essential for extensive disease 1, 8
  • Do not stop treatment based only on clinical improvement—mycological cure (negative microscopy and culture) is the definitive endpoint, as clinical appearance may improve while infection persists 8, 3
  • Do not confuse extensive tinea corporis with other conditions that may present with multiple lesions (eczema, psoriasis, nummular dermatitis) 5

References

Guideline

Determining Extent of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tinea Corporis Causative Organisms and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tinea corporis: an updated review.

Drugs in context, 2020

Research

Diagnosis and management of tinea infections.

American family physician, 2014

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Guideline

Diagnosis and Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.